Open Orphan #ORPH – Final results Reveal Record revenues and EBITDA-profitability accompanied by significant operational progress June 7, 2022 – Posted in: Blog, Open Orphan (ORPH)

Open Orphan (AIM: ORPH), a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces its audited final results for the 12 months ended 31 December 2021. Financial highlights ·       Record revenues of £39.0m (2020: £22.2m) achieved representing 76% growth ·       £9m improvement in EBITDA generating £2.9m (2020: £(6.1)m) ·       Cash and cash equivalents as at 31 December 2021 of £15.7m…